Source:http://linkedlifedata.com/resource/pubmed/id/11375847
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-5-28
|
pubmed:abstractText |
To test whether modulations of spinal serotonin (5-HT) levels would affect the development of morphine tolerance, we treated rats with either intrathecal 5-HT or 5,7-dihydroxytryptamine (5,7-DHT; a 5-HT neurotoxin) in addition to systemic infusion with morphine (2 mg x kg(-1) x h(-1)). Continuous infusion of 5-HT (10 microg x 6 microL(-1) x h(-1)) into the lumbar subarachnoid space of rats for 9 h accelerated the development of morphine tolerance. The area under the curve for the tail-flick latency test was 454.1 +/- 35.1 in the Sham Control group vs 327.6 +/- 41.0 in the 5-HT-Infused group. mu-opioid receptor binding in the lumbar spinal cord showed a decrease in the Bmax (maximal binding -46.5%), but not the binding affinity (Kd), in 5-HT-infused rats. However, intrathecal injection of 5,7-DHT (50 microg), which resulted in a 48% reduction in 5-HT and 51% reduction in 5-hydroxyindoleacetic acid concentrations, led to an attenuation of morphine tolerance (the area under the curve was 613.0 +/- 24.7 in the 5,7-DHT-Lesioned group). The binding study indicated that the affinity of lumbar micro-opioid receptors decreased 196% in 5-HT-depleted rats, whereas there was no effect on apparent binding. The infusion of 5-HT (10 microg x 6 microL(-1) x h(-1)) was not analgesic and the 5,7-DHT-induced lesion did not affect acute morphine-induced analgesia. We conclude that activity of spinal 5-HT-containing neurons plays a crucial role during the development of morphine tolerance.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5,7-Dihydroxytryptamine,
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, mu,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0003-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1563-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11375847-5,7-Dihydroxytryptamine,
pubmed-meshheading:11375847-Analgesics, Opioid,
pubmed-meshheading:11375847-Animals,
pubmed-meshheading:11375847-Drug Tolerance,
pubmed-meshheading:11375847-Hydroxyindoleacetic Acid,
pubmed-meshheading:11375847-Injections, Intravenous,
pubmed-meshheading:11375847-Male,
pubmed-meshheading:11375847-Morphine,
pubmed-meshheading:11375847-Pain Measurement,
pubmed-meshheading:11375847-Rats,
pubmed-meshheading:11375847-Rats, Sprague-Dawley,
pubmed-meshheading:11375847-Receptors, Opioid, mu,
pubmed-meshheading:11375847-Serotonin,
pubmed-meshheading:11375847-Serotonin Agents,
pubmed-meshheading:11375847-Spinal Cord
|
pubmed:year |
2001
|
pubmed:articleTitle |
Modulations of spinal serotonin activity affect the development of morphine tolerance.
|
pubmed:affiliation |
Department of Anesthesiology, Chang-Gung Memorial Hospital, Taiwan, ROC.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|